{"Symbol": "ANIK", "AssetType": "Common Stock", "Name": "Anika Therapeutics Inc", "Description": "Anika Therapeutics, Inc., is a joint preservation company in the United States, Europe, and internationally. The company is headquartered in Bedford, Massachusetts.", "CIK": "898437", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "HEALTHCARE", "Industry": "DRUG MANUFACTURERS - SPECIALTY & GENERIC", "Address": "32 WIGGINS AVENUE, BEDFORD, MA, UNITED STATES, 01730", "OfficialSite": "https://www.anika.com", "FiscalYearEnd": "December", "LatestQuarter": "2025-09-30", "MarketCapitalization": "147241000", "EBITDA": "-3667000", "PERatio": "None", "PEGRatio": "3.931", "BookValue": "10.18", "DividendPerShare": "None", "DividendYield": "None", "EPS": "-0.99", "RevenuePerShareTTM": "7.83", "ProfitMargin": "-0.293", "OperatingMarginTTM": "-0.116", "ReturnOnAssetsTTM": "-0.035", "ReturnOnEquityTTM": "-0.0873", "RevenueTTM": "112806000", "GrossProfitTTM": "62360000", "DilutedEPSTTM": "-0.99", "QuarterlyEarningsGrowthYOY": "-0.505", "QuarterlyRevenueGrowthYOY": "-0.059", "AnalystTargetPrice": "16", "AnalystRatingStrongBuy": "1", "AnalystRatingBuy": "1", "AnalystRatingHold": "0", "AnalystRatingSell": "0", "AnalystRatingStrongSell": "0", "TrailingPE": "-", "ForwardPE": "39.37", "PriceToSalesRatioTTM": "1.305", "PriceToBookRatio": "1.004", "EVToRevenue": "1.01", "EVToEBITDA": "-72.65", "Beta": "0.43", "52WeekHigh": "18.34", "52WeekLow": "7.87", "50DayMovingAverage": "9.62", "200DayMovingAverage": "10.07", "SharesOutstanding": "14421200", "SharesFloat": "12387200", "PercentInsiders": "4.884", "PercentInstitutions": "80.518", "DividendDate": "None", "ExDividendDate": "None"}